![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Apotex Pharmachem India Pvt. Ltd Bangalore In, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Letrozole, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2011-066 - Rev 00
This Chemical Type CEP, issued on May 24, 2013, remains in force until May 29, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 2334 associated with this CEP further emphasizes